Acute lymphoblastic leukemia--on the wings of IKAROS.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

1. Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma.International journal of hematology · 2017
   Trial
2. The IKAROS Transcription Factor Gene IKZF1 as a Critical Regulator in the Pathogenesis of Childhood Acute Lymphoblastic Leukemia: Insights from a Bangladeshi Population.Indian journal of clinical biochemistry : IJCB · 2025
   Article
3. An integrated classification of tumor suppressorHemaSphere · 2024
   Article
4. Lineage-specific 3D genome organization is assembled at multiple scales by IKAROS.Cell · 2023
   Article
5. Next-generation sequencing-based analysis to assess the pattern of relapse in patients with Philadelphia-positive acute lymphoblastic leukemia.EJHaem · 2022
   Article
6. Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like-Recent Progress in Treatment.International journal of molecular sciences · 2021
   Review
7. Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies.Molecular therapy. Nucleic acids · 2018
   Review
8. Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia.Nature immunology · 2014
   Article
9. Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia.Frontiers in oncology · 2014
   Review
10. Transcriptional regulation of the Ikzf1 locus.Blood · 2013
    Article
11. Ikaros is required to survive positive selection and to maintain clonal diversity during T-cell development in the thymus.Blood · 2013
    Article
12. Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis.Immunity · 2010
    Article
13. DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma.Blood · 2010
    Article
14. The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party.Haematologica · 2010
    Article
15. Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells.Immunity · 2009
    Article
16. Alternative Splice Variants Modulates Dominant-Negative Function of Helios in T-Cell Leukemia.PloS one
    Article

Corrections and comments

• Comment on
  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.2009

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as